期刊文献+

2001—2010年临床分离阴沟肠杆菌的分布及耐药性变迁 被引量:8

Distribution and changing pattern of antibiotic resistance in Enterobacter cloacae isolates during year 2001—2010
下载PDF
导出
摘要 目的了解广西医科大学第三附属医院临床分离阴沟肠杆菌的分布和耐药性的变迁。方法对该院2001—2010年临床分离的阴沟肠杆菌,进行细菌鉴定和药敏试验。结果 2001—2010年共分离出930株阴沟肠杆菌,其中分离于痰标本498株、咽拭子32株、尿标本162株、血液标本30株、分泌物155株、其他体液3株。药敏试验结果显示阴沟肠杆菌对氨苄西林和头孢唑林的耐药率最高;对哌拉西林-他唑巴坦耐药率较低;对亚胺培南耐药率最低,对氟喹诺酮类的耐药率上升较快。结论阴沟肠杆菌的耐药情况日趋严重,并出现了对碳青霉烯类抗生素不敏感株,应采取相应的控制措施以遏制耐药株的增长。 Objective To investigate the distribution and changing pattern of antibiotic resistance in Enterobacter cloacae isolates in the Third Affiliated Hospital of Guangxi University of Medical Sciences. Methods A total of 930 clinical strains of E. cloacae were collected from 2001 to 2010. Antimicrobial susceptibility testing was performed for these strains. Results The source of these isolates included sputum (498), pharyngeal swab (32), urine (162), blood (30), secretions (155), and body fluid (53). The percentage of E. cloacae resistant to ampieillin and cefazolin was the highest, but relatively lower to piperaeillin-tazobactam. These strains showed the lowest resistance rate to imipenem. The resistance rate to fluoroquinolone was rising quickly. Conclusions The antimicrobial resistance of E. cloacae was serious. Especially, carbapenems-resistant isolate was identified. Effective control measures should be taken to curb the increase of such resistant strains.
出处 《中国感染与化疗杂志》 CAS 北大核心 2012年第1期39-41,共3页 Chinese Journal of Infection and Chemotherapy
关键词 阴沟肠杆菌 抗感染 细菌耐药性 Enterobacter cloacae anti-infective bacterial resistance
  • 相关文献

参考文献7

二级参考文献56

  • 1顾怡明,张杰,俞云松,周志慧,杜小玲.多重耐药阴沟肠杆菌流行状况及耐药机制的研究[J].中华医院感染学杂志,2004,14(12):1321-1324. 被引量:63
  • 2马越,李景云,张新妹,许明哲,张力,胡昌勤,金少鸿.1995~2002年阴沟肠杆菌临床分离株的耐药性分析[J].四川生理科学杂志,2004,26(1):1-4. 被引量:13
  • 3陈晓玲.阴沟肠杆菌耐药机制的研究进展[J].中国抗感染化疗杂志,2005,5(5):310-313. 被引量:21
  • 4熊自忠,李涛,徐元宏,李俊.3株含qnr基因肺炎克雷伯菌中超广谱β-内酰胺酶的检测[J].中国药理学通报,2006,22(3):325-328. 被引量:7
  • 5丁娟娟,吕晓菊,宗志勇,熊亚莉.阴沟肠杆菌血流感染52例临床分析[J].中国感染与化疗杂志,2007,7(2):116-118. 被引量:9
  • 6Iabadene H, Messai Y, Ammari H, et al. Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria [J]. J Antimicrob Chemother, 2008,62 ( 1 ) : 133-136.
  • 7Moriguchi N, Itahash Y, Tabata N, et al. Outbreak of CTX-M- 3 type extended spectrum beta-lactamase-producing Enterobacter cloacae in a pediatric ward [J]. J Infect Chemother,2007,13(4) : 263-266.
  • 8Manzur A, Tubau F, Pujol M, et al. Nosocomial outbreak due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae in a cardiothoracicIntensive care unit [J]. J Clin Microbiol, 2007, 45(8), 2365-2369.
  • 9Touati A, Brasme L, Benallaoua S. First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacterbaumannii recovered from Algerian hospitals[J]. Diagn Microbiol Infect Dis,2008,60(3) : 287-290.
  • 10Pe'rez A, Canle D, Latasa C, et al. Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate[J]. Antimicrob Agents Chemothar, 2007,51(9) :3247- 3253.

共引文献453

同被引文献63

  • 1郭清莲,周新.医院感染革兰阴性菌的耐药性变迁[J].中华医院感染学杂志,2004,14(1):89-90. 被引量:65
  • 2李珍宇.2003~2005年临床分离细菌分布及耐药状况分析[J].临床和实验医学杂志,2007,6(6):177-179. 被引量:4
  • 3Giakkoupip P,Petrikkos G,Tzouvelekis LS,et al.Spreadof integron-associated VIM-type metallo-beta-lactamase genesamong imipenem-nonsusceptible Pseudomonas aeruginosastrains in Greek hospitals[J].J Clin microbiol,2003,41(2):822-825.
  • 4Clinical Laboratory Standard Institute. M100-S19 perform ance Standards for antimicrobial susceptibility testing [S]. PA, USA : CLSI, 2009.
  • 5Livermore DM, Warner M, Mushtaq S, et al. What remain against carbapenem - resistant Enterobacteriaceae? Evaluation of chloram- phenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitro- furantoin, temocillin and tigecycline [ J ]. Int J Antimicrob A- gents, 2011,37(5) :415-419.
  • 6中华医学会.抗菌药物敏感性试验执行标准[J].第二十三版资料增刊.中华检验医学杂志,2013,33(1):21-23.
  • 7Behera B, Mathur Das A. Ertapenem susceptibility of extended spectrum 13-1actamase-producing Enterobacteriaceae at a tertiary care centre in India[J]. Sing Me& 2009, 50(6): 628-632.
  • 8熊自忠,曹红霞,李涛,王忠新,徐元宏,李俊.临床分离阴沟肠杆菌中qnr基因及其耐药性检测[J].中华医院感染学杂志,2008,18(1):14-16. 被引量:12
  • 9Behera B, Mathur DA. Ertapenem susceptibility of ex- tended spectrum t-lactamase-producing Enterobacteriace- ae at a tertiary care centre in India[J]. Sing Med, 2009,50 (6) ,628-632.
  • 10刘军,李国明.阴沟肠杆菌耐药机制的研究进展[J].国外医药(抗生素分册),2009,30(2):49-53. 被引量:25

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部